Webinar: AMIA 2020 COVID-19 Webinar Series – Using the ACT Network to Gain Insight into COVID-19
As part of AMIA’s ongoing COVID-19 Webinar Series, we take another look at how the Clinical Research Informatics community is contributing to better understanding the clinical nature of the coronavirus. Members of the Accrual to Clinical Trials (ACT) network will present an overview of the existing network, which is funded by NIH NCATS, and will describe the goals of the ACT COVID-19 project.
Presenters will discuss how they have been able to apply proven ACT technology, governance, and Data Use Agreements to quickly implement a scalable COVID-19 research platform. Specifically, they will focus on COVID-19 extensions to the ACT query ontology, rapid implementation of a COVID-19 focused subnetwork and our process to rapidly design, develop, implement, evaluate and incrementally improve to meet the changing needs of COVID-19 research. Attendees will be able to understand how ACT fits into the variety of other efforts focused on COVID-19 research and how they can use the ACT and ACT COVID-19 project for their research.
- Lee Nadler, MD, dean, clinical and translational research, Harvard Medical School; principal Investigator, Harvard Catalyst
- Shawn Murphy, MD, PhD, professor of neurology and biomedical informatics at Harvard Medical School; chief research information officer at Partners, HealthCare; associate director of the Lab of Computer Science at MGH
- Shyam Visweswaran, MD, PhD, director of clinical informatics, Department of Biomedical Informatics, University of Pittsburgh
- Douglas MacFadden, chief informatics officer, Harvard Catalyst – Harvard Medical School